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Abstract
Biotechnology research and development in Egypt was addressed in the 2009 annual American
University in Cairo (AUC) research conference held at the AUC new campus in Cairo, Egypt, that
took place on April 5th 2009. The aim of the event was to present examples of ongoing
biotechnology research activities in Egypt with focus on agricultural and biomedical biotechnology
and to highlight the expansion of academic biotechnology research to industry.
Overview
Biotechnology is a cutting edge interdisciplinary field
combining technologies and expertise of personnel in dif-
ferent fields to contribute extensively to pharmaceutics,
diagnostics, medicine, agriculture, and the environment.
The biotechnology field literally comes in a spectrum of
colors red, white/grey [1], green and blue [2]. The confer-
ence has discussed several research endeavors in Egypt
contributing to the biotechnology field and how such
research has direct industrial applications or would direct
the expansion of the biotechnology field.
This was addressed by discussing examples of biotechnol-
ogy research and development in academia; representa-
tive participants from (1) the Center of Excellence for
Advanced Sciences (CEAS), Genetic Engineering and Bio-
technology Research Division (GEBRD), National
Research Center (NRC), in Cairo, Egypt, (2) Sinai Univer-
sity, in North Sinai, El Arish, El Masaid, Egypt, (3) Naval
Medical Research Unit-3, Abbasia, Egypt and the (4) YJ-
Science and Technology Research Center, (5) the Biology
Department, and the Biotechnology Graduate Program at
the American University in Cairo. Participants gave a gen-
eral overview of ongoing research activities that would
contribute extensively to the biotechnology industry,
additionally a few examples on ongoing research and
development in biotechnology industries were discussed.
Worldwide biotechnology hotbed communities have con-
tributed to the fact that biotechnology is one of the most
renowned applied sciences of the 21st century.  In North
America several biotechnology hotbeds exist from the
southern Biotech Bay and Biotech Beach to the eastern
coast Genetown and the northern BioCanada; which not
only encompass the biotechnology industry but also the
pharmaceutical and medical device industries. The EU
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munity and is believed to be a "world leader" in biotech-
nology and pharmaceutical research and development.
AsiaBio is another proven biotechnology hotbed that has
successfully competed in the biotechnology field interna-
tionally. Egypt is part of the AfriBio biotechnology com-
munity and the conference addressed how research and
development in academia is contributing to the develop-
ment of biotechnology in industry [3].
The conference started with an overview of industrial Bio-
technology in Egypt, which is considered a hub for scien-
tific knowledge and collaborative research activities in the
region. Egypt has dealt with biotechnological needs in
several sectors including the biomedical sector by local
synthesis of needed biotechnology products. For example
in the biomedical field, collaboration with international
organizations has allowed the production of recombinant
human insulin in several organizations. Additionally,
local Egyptian companies have successfully produced
other biological products including recombinant human
interferon -1b, erythropoietin  and streptokinase. Addi-
tionally, the biomedical and agricultural biotechnology
are expanding and the technology permits the exploration
of other potential biotechnological products. In the plant
biotechnology sector transgenic plants were engineered
that are resistant to infestations. In addition several efforts
were successfully performed to molecularly engineer
plants that are resistant to different stresses.
The first couple of talks discussed research in Trichoderma
Ressei as a potential ethanol fuel producer from cellulose
biomass. Hamza El-Dorry from the American University
In Cairo, discussed a project entitled "Genomic approach
for ethanol fuel production from cellulose" [4]. The work
of his group addressed evolution of different biochemical
pathways for energy production and provided Saccharo-
myces cerevisiae and Trichoderma Ressei as model systems.
They have previously utilized expressed sequence tag anal-
ysis and cDNA microarray to investigate the metabolic
pathway involved in glucose metabolism [5]. They ana-
lyzed the expression of the enzymes involved in glycoly-
sis, tricarbocylic acid cycle and the electron transport
chain under high glucose concentration and have revealed
distinct discrepancies between these two organisms that
have allowed the understanding of the aerobic and anaer-
obic skews under high glucose concentration in both
models used. Similarly, Bishoy Hanna in Dorry's research
group at the American University in Cairo and a graduate
student in the AUC biotechnology graduate program, pre-
sented the identification of potential hexose transporters
in Trichoderma reesei, and studied their structure by in-silico
analysis of motifs and structure domain [6]. Dorry's group
previously analyzed the transcription activity of other glu-
cose transporter genes in T. reesei, and assessed differential
expression under altered oxygen and glucose conditions
[7]. The group believes that such rigorous study of the bio-
chemical pathways involved in energy production from
glucose will allow biotechnology application of this fun-
gus through ethanol production from cellulosic biomass.
Mahmoud Sakr, the following speaker also included
bioethanol and biofuel production in the future plan of
their organization.
Mahmoud Sakr at the Center of Excellence for Advanced
Sciences (CEAS) and Genetic Engineering and Biotechnol-
ogy Division of the National Research Center (NRC), in
Cairo, Egypt discussed ongoing research and development
that allowed the launching of new local biotechnology
products [8]. His division has a broad research entity
including plant, animal and microbial research and devel-
opment. A pilot unit for the application of genetic engi-
neering and biotechnology was also established to help in
the scaling up and process development of biotechnol-
ogy-based products. Examples of their biotechnology
diagnostic and research kits products include:
-Peroxidase and urease diagnostic kits
-Triplet PCR for HCV detection kit,
-Plasmid DNA isolation kit
Dr. Mohei ElDin Soliman, at the vaccine development
unit of the National Research Center also discussed efforts
in designing and engineering hepatic C virus vaccines.
From the agricultural biotechnology aspect they also dis-
cussed genotyping Egyptian barley resistant to net blotch
disease [9], biopesticides and biofertilizers, Virus-free
potato seeds, tissue culture plants and transgenic plants
and have outlined them as the focus of research and devel-
opment in their organization and further work is contin-
ued to develop plants resistant to stresses and infections.
Rose Lines, from the Department of Primary Industries,
Victoria, Australia discussed molecular diagnostics tools
used in the identification of strawberry viruses in Australia
[10,11]. The idea was to develop an effective, rapid and
less costly process for the indexing of the strawberry
nucleus collection in Victoria.
Applications for green (agricultural and horiculture
research and development were addressed) and white/
grey (research in biofuel) biotechnology were concluded
at this point. The red biotechnology research (biomedi-
cal) was continued, as well as a project on blue biotech-
nology (marine genomic research). Rania Siam addressed
ongoing diverse research activities in the Biotechnology
Graduate Program, Biology Department and the YJ-Sci-
ence and Technology Research Center at AUC that are aPage 2 of 5
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Siam outlined and discussed the following selected
research topics:
-Genetic variations and molecular disease discovery of an
isolated community in Egypt.
-Molecular and genomic approach to investigate links
between infectious diseases and cancer development.
-Role of cell cycle proteins in maintaining genomic integ-
rity in a eukaryotic model system.
-Structural and functional analysis of diverse strains of
influenza genome.
-Metagenomic studies of marine organisms in the Red
Sea.
-Comparative metabolic profiling of selected biological
systems.
-Development and characterization of novel antibody-
based as well as molecular diagnostic tests for detection of
tumor biomarkers and infectious diseases.
-Therapeutic and diagnostic applications of nanotechnol-
ogy.
-Early prediction of tumorogenic changes in cell cycle
genes in Hepatitis C.
-Using optical traps to study the mechanical properties of
biological polymers.
-Improving durability of biomedical implants through
deposition of nanomaterials and nanocomposite thin
film using various techniques.
-Fabrication of sensors and MEMS/NEMS for controlling
the biological function of the various organs of the body.
These projects are currently being conducted in laborato-
ries and research centers at AUC including but not limited
to the YJ- Science and Technology Research Center, the
Marine Biology Laboratory at the John Gerhardt Field Sta-
tion in Al-Gouna and laboratories in several other depart-
ments at AUC. Additionally, collaboration with local
research institutes as the National Research Center and the
US-Naval Medical Research Unit-3 as well as collabora-
tion with several international universities and research
institutes permits cutting-edge research activities that are
unique and essential for the region. One of the projects
vigorously discussed was a metagenomic study of marine
organisms in the Red Sea, which is an environmental
genomic approach for the study of microbial communi-
ties in the Red Sea. The aim of this project is to establish
an environmental genomics database for microbial com-
munities residing in unique environments in the Red Sea
and screen the database for potential Biotechnological
and pharmaceutical products. This project is a collabora-
tive research project with King Abdullah University for
Science and Technology, KSA and Woods Hole Oceano-
graphic Institute, Boston, Massachusetts.
The shift to biomedical research and development was
apparent with the focus of the remaining presentations on
cancer biology and infectious diseases epidemiology.
Ashraf Bakkar from the Biochemistry department at Sinai
University discussed different mutations in FGFR3 and
TP53 revealed by studying 81 bladder cancer tumors [13].
They suggested two distinct pathways in bladder cancer
associated with these mutations [13][14]. Additionally,
an allele specific PCR (AS-PCR) assay [15] for the detec-
tion of such mutations not just in tumor tissues but also
in patients' urine represented an exceptional diagnostic
tool. Iteration on the importance of such finding not just
to understand the mechanism of tumorogenesis but as a
diagnostic and prognostic tool in urothelial cell carci-
noma (UCC) which could have important implication in
both the diagnosis and follow up of UCC patients. Simi-
larly, Mary Boutrous from the Siam group, at the Ameri-
can University in Cairo discussed how the expression and
methylation status of the tumor suppressor gene Lats1 in
carcinoma could be a potential diagnostic and prognostic
marker [16]. She pointed out to previous work in trans-
genic mice and mammalian cell lines that revealed an
overexpression of Lats1 in selected tumors in mice (Siam
et al., unpublished results). Further, investigation revealed
that methylation status of the Lats1 promoter region
inversely correlate with Lats1 expression and interestingly
correlate with different prognostic stages of carcinoma.
Epidemiology of infectious diseases in the region was the
focus of the remaining talks that addressed the impor-
tance of infectious diseases surveillance in the region for
appropriate preventive and treatment strategies. Lamyaa
Shaaban a graduate student in the AUC Biotechnology
graduate program discussed her project at the US-Naval
Medical Research Unit-3 (NAMRU-3) in Abbassia, Cairo,
Egypt [17]. The presentation addressed Vibrio cholerae
pandemics and outbreaks [18] with emphasize on shift in
strains and prevalent serotypes. The study focused on the
genotype characterization of different epidemiologic
strains of numerous 2007 African outbreaks. Molecular
characterization of strains using polymerase chain reac-
tion (PCR), multilocus variable tandem repeat analysis
(MLVA), mulitlocus sequence typing (MLST), and DNA
sequencing for previously identified virulent genes are in
progress. Similarly, Lobna Mourad also a graduate studentPage 3 of 5
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her thesis at the US-Naval Medical Research Unit-3 in
Abbassia, Cairo, Egypt discussed the project on Extended-
spectrum -lactamases (ESBLs) [19]. She explained the
challenges with the emergence of antimicrobial resistant
strains [20,21] and discussed a study on the molecular
characterization of ESBL producing bacteria by sequence
analysis of blaCTX-M, blaSHV, and blaTEM genes and the estab-
lishment of a genotypic map of the ESBL samples using
PFGE. The last two speakers from the AUC biotechnology
graduate program and NAMRU-3 emphasized the impor-
tance of surveillance of infectious diseases in the region
for the appropriate preventive measures and effective vac-
cine and antimicrobial development.
The spectrum of colors in biotechnology was discussed.
Blue biotechnology is the focus of the current ongoing
project between the American University in Cairo, King
Abdullah University for Science and Technology and
Woods Hole Oceanographic Institute on an environmen-
tal genomics approach to analyze marine microorganisms
in the Red Sea for biotechnological and pharmaceutical
potentials. Green Biotechnology and novel approaches in
transgenic crops has been addressed in more than one
talk. Additionally, Red Biotechnology and the genetic
engineering technology was a major component of the
ongoing projects at Center of Excellence for Advanced Sci-
ences (CEAS) and Genetic Engineering and Biotechnology
Division of the National Research Center (NRC), in Cairo,
Egypt. The conference was concluded by addressing the
importance of academic research and development in
providing the platform for the spectrum of colors in bio-
technology.
Future conference
The American University in Cairo annual research confer-
ence will be held in 2010. Details on the conference will
be posted on the AUC website at http://www.auce
gypt.edu
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